Meridian Bioscience Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 8 of 8 Posts
4 Lucrative MedTech Stocks To Bet On In 2021 Amid Pandemic
Article By: Zacks Investment Research Friday, April 2, 2021 6:16 AM EDT
As 2021 progresses, investors can safely put their bets on stocks that have shown excellent prowess amid the pandemic-induced volatility and have solid growth potential.
In this article: HRC, MCK, OMI, VIVO Also: BDX
Read
Bull Of The Day: Meridian Bioscience, Inc.
Article By: Kevin Cook Monday, March 22, 2021 9:58 AM EDT
Meridian Bioscience is a $1 billion provider of diagnostic test kits for gastrointestinal and respiratory infectious diseases. The company is expected to grow sales by 28.6% this year to $326 million.
In this article: VIVO Also: NVAX, QDEL, HOLX
Read
Meridian Bioscience Checks All The Right Marks
Article By: Tickeron Wednesday, March 17, 2021 3:30 PM EDT
Meridian Biocience is a life science company that has seen strong earnings and revenue growth, is in an upward trend, and isn't terribly overvalued. There is also a sense of pessimism toward the stock from analysts.
In this article: VIVO
Read
Bull Of The Day: Meridian Bioscience (VIVO)
Article By: Kevin Cook Friday, January 8, 2021 9:13 AM EDT
Meridian Bioscience is a $900 million provider of diagnostic test kits for gastrointestinal and respiratory infectious diseases. The company is expected to grow sales 18% this year to $300 million.
In this article: VIVO Also: QDEL, HOLX, EDIT, CRSP
Read
Week In Review: Korea's Samsung BioLogics Files For $2.5 Billion IPO
Article By: ChinaBio® Today Saturday, August 13, 2016 1:13 PM EDT
Samsung BioLogics filed for an IPO on South Korea's main board that will raise between $1.8 and $2.7 billion, valuing the company at $9 billion.
In this article: BMY, CLSN, TECH, VIVO
Read
Opportunities Abound In Healthcare
Article By: Wall Street Daily Friday, February 5, 2016 3:47 PM EDT
U.S. healthcare spending amounted to $3 trillion in 2014, up 5.3% from 2013.
In this article: GSK, PETS, VIVO Also: PDLI, VRX
Read
Updating The Smart Alpha Equity Income Portfolio
Article By: Marc Gerstein Saturday, December 19, 2015 2:56 PM EDT
On October 24th, I introduced the Smart Alpha Equity Income model. With three months having past since the portfolio was initially put together, it’s time to publish and updated list of stocks and look in on how the model has fared since it went live
In this article: CMP, COH, EMR, FII, GES, IBM, LVS, MO, MOS, MRK, NOV, NUS, PKG, PM, WDR, WNR, CPSI, VIVO, DVY, SPY, VIG, XLU, HCI
Read
Chart Of The Day - Meridian Bioscience (VIVO)
Article By: Jim Van Meerten Thursday, January 9, 2014 10:36 AM EDT
Meridian Bioscoence (VIVO) is a fully integrated life sciences company. Since the Trend Spotter signaled a buy on 12/13 the stock is up 7.85%.
In this article: VIVO
Read
1 to 8 of 8 Posts